Myasthenia triggered by immune checkpoint inhibitors: New case and literature review

Melanoma and Skin CancerImmunotherapy

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

J Clin Neuromuscul Dis.

Supakornnumporn S, Katirji B

doi: 10.1097/ CND.0000000000000193.

Melanoma and Skin Cancer

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Br J Dermatol.

Gault A, Anderson AE, Plummer R, Stewart C, Pratt AG, Rajan N

doi: 10.1111/bjd.19750.Visit the original publication at ncbi.nlm.nih.gov

Immunotherapy

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

Rev Mal Respir.

Eberst G, Lakhzoum W, Tomasini P, Andreotti N, Abcaya J, Mascaux C, Barlesi F

doi: 10.1016/j.rmr.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Acquired generalized lipodystrophy under immune checkpoint inhibition

Br J Dermatol.

Haddad N, Vidal-Trecan T, Baroudjian B, Zagdanski AM, Arangalage D, Battistella M, Gautier JF, Lebbe C, Delyon J, PATIO group

doi: 10.1111/bjd.18124.

Immunotherapy

Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literature

Immunotherapy.

Rebuzzi SE, Bregni G, Grassi M, Damiani A, Buscaglia M, Buti S, Fornarini G

doi: 10.2217/imt-2018-0042.

Melanoma and Skin CancerImmunotherapy

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease

Br J Dermatol.

Weber J, Glutsch V, Geissinger E, Haug L, Lock JF, Schneider F, Kneitz H, Goebeler M, Schilling B, Gesierich A

doi: 10.1111/bjd.18739.

Melanoma and Skin Cancer

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Melanoma Res.

Thummalapalli R, Melms JC, Mier J, Izar B

doi: 10.1097/CMR.0000000000000646.

Immunotherapy

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature

Mycopathologia.

Oltolini C, Ripa M, Andolina A, Brioschi E, Cilla M, Petrella G, Gregorc V, Castiglioni B, Tassan Din C, Scarpellini P

doi: 10.1007/s11046-018-0291-4.

Melanoma and Skin Cancer

[Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma]

Ann Dermatol Venereol.

Malmontet T, Dousset L, Gerard E, Ouhabrache N, Pham-Ledard A, Beylot-Barry M

doi: 10.1016/j.annder.2019.08.019.

Related content

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

Acquired generalized lipodystrophy under immune checkpoint inhibition

Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literature

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature

[Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma]